- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
ImaRx Therapeutics, Inc.
(NASDAQ:IMRX)Key Stats & Ratios
| Valuation | |
| Market Cap | 182.98K |
| P/E | — |
| P/E (Trailing) | -0.03 |
| P/E (Forward) | — |
| Price/Sales | 0.01 |
| Price/Book | 0.25 |
| EPS | -0.49 |
| EPS Growth (ttm) | — |
| Fiscal Year | |
| Fiscal Year Ends | Dec 31 |
| Last Quarter | Jun 2008 |
| Profitability | |
| Operating Income | -17635000.00 |
| Net Income | -12229000.00 |
| Profit Margin (ttm) | — |
| Operating Margin (ttm) | -2.09% |
| Management Effectiveness | |
| Return on Assets (ttm) | -358.40% |
| Return on Equity (ttm) | — |
| EBIT Margin (ttm) | — |
| SEC Filings | |
| Latest Form 10-Q (Quartely) | |
| Latest Form 10-K (Annual) | |
Financials
| Income Statement | |
| Total Enterprise Value | -2337343.00 |
| Revenue | 8.42M |
| Revenue/Share | 0.83 |
| Revenue Growth (ytd) | 1.10% |
| Annual Revenue Growth Rate (3Y) | 153.57% |
| Annual Income Growth Rate (3Y) | — |
| Earnings Growth (ytd) | — |
| Gross Operating Profit (ttm) | 5.78M |
| EBITDA | -6838000.00 |
| Diluted EPS (ttm) | -0.49 |
| Balance Sheet | |
| Total Cash | 2.44M |
| Total Cash/Share | 0.24 |
| Total Assets | 3.41M |
| Total Liabilities | 2.96M |
| Total Debt/Equity | — |
| Long Term Debt Common Equity Ratio | — |
| Current Ratio | 1.00 |
| Leverage Ratio | 7.00 |
| Book Value/Share | 0.04 |
| Cash Flow | |
| Cash Flow | -11410000.00 |
| Free Cash Flow | -6511000.00 |
| Cash Flow/Share | -1.12 |
| Free Cash Flow/Share | -0.64 |
Trading Information
| Stock Price History | |
| Beta | — |
| 52Wk Change | -98.60% |
| 52Wk Change Vs. Mkt | -98.00% |
| 52Wk High | 1.77 |
| 52Wk Low | 0.01 |
| 10 Day Moving Average | 0.02 |
| 200 Day Moving Average | 0.21 |
| Share Statistics | |
| Average Volume | 27.50K |
| Shares Outstanding | 10.17M |
| Shares Float | 8.46M |
| % Held by Insiders | 16.80% |
| % Held by Institutions | 1.10% |
| Shares Short | — |
| Short Ratio | — |
| Short % of Float | — |
| Dividends & Splits | |
| Dividend Date | — |
| Dividend Yield | — |
| Dividend Amount | — |